These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23754111)
21. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise. Treloar C; Valentine K Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673 [No Abstract] [Full Text] [Related]
22. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society. Mamber N Cornell J Law Public Policy; 2006; 15(3):619-64. PubMed ID: 17593583 [No Abstract] [Full Text] [Related]
23. Towards good governance in drug policy: evidence, stakeholders and politics. MacGregor S; Singleton N; Trautmann F Int J Drug Policy; 2014 Sep; 25(5):931-4. PubMed ID: 25086908 [No Abstract] [Full Text] [Related]
24. The drug abuse problem in Sri Lanka. Jayasuriya DC Med Law; 1995; 14(1-2):37-43. PubMed ID: 7666746 [TBL] [Abstract][Full Text] [Related]
25. Abuse liability and the regulatory control of therapeutic drugs: untested assumptions. Woods JH Drug Alcohol Depend; 1990 Apr; 25(2):229-33. PubMed ID: 1970287 [No Abstract] [Full Text] [Related]
26. Social policy issues in narcotics abuse. Schmolling P J Health Soc Policy; 1993; 5(2):49-65. PubMed ID: 10171762 [TBL] [Abstract][Full Text] [Related]
27. The physician as a servant of public policy. Stimmel B Mt Sinai J Med; 1991 Oct; 58(5):433-6; discussion 437-42. PubMed ID: 1753983 [No Abstract] [Full Text] [Related]
28. Doctors urge public health led approach to drugs policy. Gulland A BMJ; 2016 Jun; 353():i3387. PubMed ID: 27311946 [No Abstract] [Full Text] [Related]
29. The USA shifts away from the "war on drugs". Morris K Lancet; 2009 Apr; 373(9671):1237-8. PubMed ID: 19367740 [No Abstract] [Full Text] [Related]
32. An all-embracing problem description. The Swedish drug issue as a political catalyst 1982-2000. Edman J Int J Drug Policy; 2013 Nov; 24(6):558-65. PubMed ID: 23790617 [TBL] [Abstract][Full Text] [Related]
33. Drug use and public policy. Murtaugh JB Mt Sinai J Med; 1991 Oct; 58(5):423-6; discussion 437-42. PubMed ID: 1753981 [No Abstract] [Full Text] [Related]
34. Supply reduction's hidden casualties: a view from the trenches. Strathdee SA; Patterson TL Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337 [No Abstract] [Full Text] [Related]
35. Harm reduction is now the mainstream global drug policy. Wodak A Addiction; 2009 Mar; 104(3):343-5; discussion 345-6. PubMed ID: 19207340 [No Abstract] [Full Text] [Related]
36. A quagmire for our time: the war on drugs. Schrag P J Public Health Policy; 2002; 23(3):286-98. PubMed ID: 12325286 [No Abstract] [Full Text] [Related]
37. Licit and illicit drug policies: a typology. Warner KE; Citrin T; Pickett G; Rabe BG; Wagenaar A; Stryker J Br J Addict; 1990 Feb; 85(2):255-62. PubMed ID: 2317593 [TBL] [Abstract][Full Text] [Related]
38. Harm reduction is a good label for a criterion all drug programs should meet. Maccoun RJ Addiction; 2009 Mar; 104(3):341-2; discussion 345-6. PubMed ID: 19207338 [No Abstract] [Full Text] [Related]
39. The Vienna declaration. Neudorf C; di Ruggiero E; Lynkowski D; Beanlands H; Bell B; Finlay J; Fridkin A; Maxted JM; McIntyre L; Turner S Can J Public Health; 2010; 101(4):271. PubMed ID: 21033528 [No Abstract] [Full Text] [Related]